BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Dev California Life Sciences - ECPv6.1.2.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Dev California Life Sciences
X-ORIGINAL-URL:https://dev.califesciences.org
X-WR-CALDESC:Events for Dev California Life Sciences
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220512T090000
DTEND;TZID=America/Los_Angeles:20220512T100000
DTSTAMP:20260407T105233
CREATED:20220419T195644Z
LAST-MODIFIED:20220420T154527Z
UID:8076-1652346000-1652349600@dev.califesciences.org
SUMMARY:IQVIA - Critical Success Factors For Commercialization Series - Preparing to Enter the Market: A Focus on Market Access
DESCRIPTION:The number of biopharma and biotech companies developing and launching new therapies is continuing to rise with emerging biopharma remaining a strong source of innovation. At the same time\, more barriers to success are emerging with requirements for increasingly complex clinical trials\, continuous regulatory changes\, evolving payer conditions\, and more restrictive access to HCPs. \nIt’s evident that asset success starts early\, with a need to ensure evidence generation delivers endpoints that demonstrate value to regulators\, payers\, prescribers\, and patients. Communicating that value requires an adaptable\, omnichannel approach to activate and engage all stakeholders for launch and throughout the product lifecycle. \nLearn how IQVIA is helping clinical and commercial customers bring therapies to market and to the patients who need them. \nIQVIA experts will break down the components of successful commercialization for emerging biopharma and biotech companies. \nPreparing to Enter the Market: A Focus on Market Access \nAsset success relies on strong engagement with the key stakeholders who will influence the path to the patient. Learn from IQVIA experts as they share key considerations for emerging biopharma companies who need to establish market access in the U.S. \nRegister» \nAsk the experts \nIQVIA experts will take your questions at the end of each session. If they are unable to address every question live\, they will follow up with an answer individually to ensure you have the information you need.
URL:https://dev.califesciences.org/event/iqvia-critical-success-factors-for-commercialization-series-preparing-to-enter-the-market-a-focus-on-market-access/
LOCATION:Live\, Online
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-13.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220518T090000
DTEND;TZID=America/Los_Angeles:20220518T120000
DTSTAMP:20260407T105233
CREATED:20220419T200018Z
LAST-MODIFIED:20220420T163902Z
UID:8078-1652864400-1652875200@dev.califesciences.org
SUMMARY:IQVIA – Critical Success Factors For Commercialization Series – Asset Success Starts Early: Demonstrating and Communicating the Value of Your Therapy
DESCRIPTION:The number of biopharma and biotech companies developing and launching new therapies is continuing to rise with emerging biopharma remaining a strong source of innovation. At the same time\, more barriers to success are emerging with requirements for increasingly complex clinical trials\, continuous regulatory changes\, evolving payer conditions\, and more restrictive access to HCPs. \nIt’s evident that asset success starts early\, with a need to ensure evidence generation delivers endpoints that demonstrate value to regulators\, payers\, prescribers\, and patients. Communicating that value requires an adaptable\, omnichannel approach to activate and engage all stakeholders for launch and throughout the product lifecycle. \nLearn how IQVIA is helping clinical and commercial customers bring therapies to market and to the patients who need them. \nIQVIA experts will break down the components of successful commercialization for emerging biopharma and biotech companies. \nAsset Success Starts Early: Demonstrating and Communicating the Value of Your Therapy \nIQVIA experts will share perspectives on how emerging biopharma companies can demonstrate and communicate the value of new therapies by engaging thought leaders to ensure their innovation reaches the patients who need it. \nRegister» \nAsk the experts \nIQVIA experts will take your questions at the end of each session. If they are unable to address every question live\, they will follow up with an answer individually to ensure you have the information you need.
URL:https://dev.califesciences.org/event/iqvia-critical-success-factors-for-commercialization-series-asset-success-starts-early-demonstrating-and-communicating-the-value-of-your-therapy/
LOCATION:Live\, Online
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-13.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220519T090000
DTEND;TZID=America/Los_Angeles:20220519T100000
DTSTAMP:20260407T105233
CREATED:20220419T200521Z
LAST-MODIFIED:20220420T155511Z
UID:8080-1652950800-1652954400@dev.califesciences.org
SUMMARY:IQVIA - Critical Success Factors For Commercialization - Innovative Customer Engagement Models
DESCRIPTION:The number of biopharma and biotech companies developing and launching new therapies is continuing to rise with emerging biopharma remaining a strong source of innovation. At the same time\, more barriers to success are emerging with requirements for increasingly complex clinical trials\, continuous regulatory changes\, evolving payer conditions\, and more restrictive access to HCPs. \nIt’s evident that asset success starts early\, with a need to ensure evidence generation delivers endpoints that demonstrate value to regulators\, payers\, prescribers\, and patients. Communicating that value requires an adaptable\, omnichannel approach to activate and engage all stakeholders for launch and throughout the product lifecycle. \nLearn how IQVIA is helping clinical and commercial customers bring therapies to market and to the patients who need them. \nIQVIA experts will break down the components of successful commercialization for emerging biopharma and biotech companies. \nInnovative Customer Engagement Models \nWhile the value of face-to-face\, personal HCP interactions remain impactful\, the efficacy\, adoption\, and ROI of digital\, non-personal engagement continues to increase. IQVIA experts will discuss the imperatives for an agile and flexible engagement model for emerging biopharma; one that’s fit for today’s realities while being ready for what tomorrow will bring. \nRegister» \nAsk the experts \nIQVIA experts will take your questions at the end of each session. If they are unable to address every question live\, they will follow up with an answer individually to ensure you have the information you need.
URL:https://dev.califesciences.org/event/iqvia-critical-success-factors-for-commercialization-innovative-customer-engagement-models/
LOCATION:Live\, Online
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-13.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220811T090000
DTEND;TZID=America/New_York:20220811T130000
DTSTAMP:20260407T105233
CREATED:20220414T195142Z
LAST-MODIFIED:20220420T164018Z
UID:7834-1660208400-1660222800@dev.califesciences.org
SUMMARY:Public Health & Its Access to Historically Excluded Communities\, Pt. 4  Actualizing Change
DESCRIPTION:In jurisdictions as large and diverse as California\, the understanding of health equity and how to apply best practices could not be more pressing. Improving and assuring racial equity above racial equality has been shown to reduce inequity in healthcare outcomes through community-level investment\, equitable leadership development\, and most importantly increased access to timely and culturally responsive healthcare and treatment. Please join Ace Robinson\, California Life Sciences\, and Center for Excellence in Nonprofits for this four-part series exploring these topics. Participants will leave with a customized playbook on how to increase access and improve health outcomes for historically excluded communities. \nRegister»
URL:https://dev.califesciences.org/event/public-health-its-access-to-historically-excluded-communities-pt-4-actualizing-change/
LOCATION:Live\, Online
CATEGORIES:Member Events,Professional Development
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-12.jpg
END:VEVENT
END:VCALENDAR